Improve skin hydration, skin elasticity and nourish the skin from the inside out.

JUVEDERM® VOLITE $550 per syringe

Volite is an innovative hyaluronic acid (HA) based injectable treatment designed to improve skin quality for up to 9 months. This new skin conditioning treatment hydrates the skin from within increasing the production of elastin, collagen and hyaluronic acid – three key factors in youthful skin. The result: smoother, plumper and younger looking skin. Volite can be used on face, neck, décolletage and hands


Volite works to plump up the skin by delivering hyaluronic acid (HA) into the dermis to increase hydration and stimulate collagen production resulting in smoother skin texture, increased elasticity and increased hydration. Volite is not a typical dermal filler, it works on the condition and quality of the skin through unique patented VYCROSS® technology.


VOLITE can be used on your face for:

• Fine lines & wrinkles including crows feet (outer corners of the eyes

• Crepiness  (wrinkled surface like crepe paper) around mouth and cheeks

• Acne scarring

• Skin laity

• General skin quality

VOLITE can be also be used on the Chest & Hands for:

• Skin laxity

• Fine lines

• Veins and hollows on back of hands


The Volite treatment involves making a number of micro-injections into the skin of the target area with a tiny needle. Our clincians will begin by prepping you for your treatment which involves cleaning the area to be treated. Dr. Barnard will inject small amounts of Volite directly into the treatment area. A typical treatment takes approximately 15-20 minutes.

After the treatment is finished, you may experience common side effects related to the site of injection, these include bruising, redness, swelling, and tenderness. To control these side effects, it’s best to avoid such things as extreme temperatures, swimming, going into hot tubs, excessive sun exposure and drinking alcohol. This may last for a couple of days. You’ll need to avoid using makeup for about 24 hours afterward to minimize the risk of infection.


Improvement in skin tone and hydration are typically visible 2 weeks post-injection. Results continue to improve. Clinical trials have shown improved skin hydration and elasticity lasting up to 9 months.

• VOLITE must not be used in:
– Patients suffering from untreated epilepsy;
– Patients who tend to develop hypertrophic scarring;
– Patients with known hypersensitivity to hyaluronic acid and/or to gram positive bacterial proteins as hyaluronic acid is produced byStreptococcus type bacteria;
– Patients with known hypersensitivity to lidocaine or to amide-type local anaesthetics;
– Patients suffering from porphyria;
– Women who are pregnant or breastfeeding;
– Children.
• Volite must not be used in areas presenting cutaneous inflammatory and/or infectious processes (acne, herpes, etc.).
• Volite should not be used simultaneously with laser treatment, deep chemical peels or dermabrasion. For surface peels, it is recommended not to inject the product if the inflammatory reaction generated is significant.

Side effect include, but are not limited to:
• Inflammatory reactions (redness, oedema, erythema, etc.) which may be associated with itching and/or pain on pressure and/or paresthesia, occurring after the injection. These reactions may last for a week.
• Haematomas.
• Induration or nodules at the injection site.
• Staining or discolouration of the injection site might be observed, especially when HA dermal filler is injected too superficially and/or in thin skin (Tyndall effect).
• Poor effect or weak filling effect.
• Rare but serious adverse events associated with intravascular injection of dermal fillers in the face and tissue compression have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis and damage to underlying structures. Immediately stop the injection if a patient exhibits any of the following symptoms, including changes in the vision, signs of stroke, blanching of the skin or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and possibly evaluation by an appropriate medical practitioner specialist should an intravascular injection occur. Abscesses, granuloma and immediate or delayed hypersensitivity after hyaluronic acid and/or lidocaine injections have also been reported. It is therefore advisable to take these potential risks into account.
• Patients must report inflammatory reactions which persist for more than one week, or any other side effect which develops, to their medical practitioner as soon as possible.